Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. The company's platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. The company's platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals.
Ginkgo Bioworks Reports Third Quarter 2024 Financial Results PR Newswire BOSTON, Nov. 12, 2024 Ginkgo provides update on its restructuring process including an acceleration of site consolidation...
Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing PR Newswire BOSTON, Nov. 12, 2024 BOSTON, Nov. 12, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.48 | -27.9594137542 | 8.87 | 9.04 | 5.97 | 1905591 | 6.61555541 | CS |
4 | -2.86 | -30.9189189189 | 9.25 | 10.07 | 5.97 | 1219235 | 7.61524967 | CS |
12 | -0.86 | -11.8620689655 | 7.25 | 10.07 | 5.26 | 1322385 | 7.38141336 | CS |
26 | -24.574 | -79.3631313784 | 30.964 | 30.964 | 5.26 | 26537910 | 15.09033357 | CS |
52 | -54.01 | -89.4205298013 | 60.4 | 75.2 | 5.26 | 27695264 | 30.89677339 | CS |
156 | -524.41 | -98.7961567445 | 530.8 | 549.6 | 5.26 | 23216691 | 76.5476949 | CS |
260 | -443.21 | -98.5787366548 | 449.6 | 634.56 | 5.26 | 22353835 | 85.19788105 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales